We describe a simplified method for measuring free, total, and antibody-bound insulin in insulin-treated patients in whom antibodies to insulin are present. 
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We describe a simplified method for measuring free, total, and antibody-bound insulin in insulin-treated patients in whom antibodies to insulin are present. The free, active insulin is extracted from the serum with a polyethylene glycol solution. Total Insulin is extracted from the serum with a polyethylene glycol solution after dissociation of the antibody-antigen complex with dilute HC1. Aliquots of the extracts are used in the radloimmunoassay system. The figure for antibody-bound Insulin is the difference between the total and free insulin values and reflects the concentration of insulin antibodies present. A commercially available ("Phadebas") radloimmunoassay for immunoreactive
Insulin was used to quantitate the insulin present in the two extracts. Recovery of added insulin averaged 85% for the free insulin and 87% for the total insulin. (6, 7) .
Here, we describe the use of PEG to extract free insulin from serum and also total insulin after the antibody-antigen complex has been dissociated with HC1 (1 mol/liter).
We then used the "Phadebas Insulin Test" to assay the extracts as a means of speeding the entire procedure (from three to four days to less than a day) and of simplifying the radioimmunoassay step. vs. the logarithm of insulin concentration on linear-log graph paper. Alternatively, the percentage values for the insulin standards may be plotted vs. the logarithm of insulin concentration on logit-log paper, which gives a straight line. Read the concentration of insulin directly from the curve for each of the unknown samples. If serum is used in this procedure without pretreatment, the concentration in microunits/ml is read directly from the standard curve with no further calculation.
Materials and Methods
Equipment
The free insulin in the PEG extract is calculated by multiplying the reading from the standard curve by 2.0. The factor 2.0 is used to correct for the dilution of serum with PEG.
The total insulin in the PEG extract is calculated by multiplying the reading from the standard curve by 2.8. The factor 2.8 corrects for the dilution of serum.
The antibody-bound insulin may then be calculated: bound insulin = total insulin -free insulin.
Results
Effects of PEG on the Radioimmunoassay System
The effects of PEG on the zero concentration count, which is used to calculate the percentage count rate for both the standards and unknowns, were determined by comparing duplicate counts for tubes containing 0.1 ml of buffer, 0.1 ml of labeled ligand, and 1.0 ml of antibody-Sephadex (H-tubes) with duplicate counts for tubes containing 0.1 ml of PEG, 0.1 ml of labeled ligand, and 1.0 ml of antibody-Sephadex suspension (HP-tubes).
The tubes were then taken through the prescribed procedure of 
Comparison Method
The "Phadebas Insulin Test," with use of serum, was the method to which results for both the free and total insulin extraction methods were compared. These correlation studies were done on serum from subjects who had never been treated with insulin and who therefore had no insulin antibodies present in their circulating blood to interfere with the in vitro radioimmunoassay of insulin.
Forty serum samples, both from normal subjects and non-insulin-treated diabetic patients, were assayed by the comparison method, the method for free insulin, and that for total insulin. Figures 1-3 
Hydrogen Ion Concentration
We studied the effects of hydrogen ion concentration on the extraction system as well as on the dissociation procedure.
The pH of the PEG solution was 6.7 ± 0.1. When 1.0 ml of human serum was mixed with 1.0 ml of the PEG solution, the resulting pH was 8.42 ± 0.10, a pH range that surprised us but agrees with data reported by Desbuquois and Aurbach (2), who studied the solubility of the free hormone in PEG solutions. Apparently the precipitation of proteins shifts the pH to the alkaline side. They reported that as the pH was decreased from 9 to 7 there was no decrease in solu- Occasionally in preparing the total insulin extract, we encountered a serum sample that produced a turbid extract that was difficult to separate into two phases by centrifugation. Additidn of 0.2 ml of 1 mol/ liter NaOH to such specimens gave a pH of 9.3 to 9.5, and the pH remained above 9.0 even after PEG was added. At such pH's the PEG does not properly precipitate the protein molecules, resulting in turbidity in the upper phase. Such specimens can be salvaged by adding 1 drop (50 l) of 0.5 mol/liter HC1, to adjust the pH to 7.9-9.0. Dilute NaOH must be very carefully added to the total insulin PEG extract; very little acid or base can tremendously affect the pH.
Recovery
Analytical recoveries of insulin added to serum were measured on serum, PEG free insulin extract, and PEG total insulin extract, in concentrations corresponding to the ranges normally encountered in clinical testing.
Pooled serum from patients with low insulin concentrations was assayed in triplicate by the comparison method and found to contain 16 microunits of insulin per milliliter.
The pool was tested for insulinbinding antibodies by measuring the free and the total insulin and found to be free of any antibodies to insulin. It was then divided into three aliquots and standard porcine insulin (320 microunits/ml) was added to adjust the total insulin concentration to 59.7, 124.3, and 194 microunits/ml (pools 1 to 3, respectively.) Table 1 shows the results of the recovery study. The mean percent recovery, for all concentrations, for each method was: "Phadebas" method with direct use of the serum pools, 90.5%; the free-insulin method, 84.5%; and the total-insulin method, 86.5% of the theoretical value. Recovery for the comparison method was 80% or more at each concentration, the lowest recovery being at the 124 microunits/ml concentration. For the free-insulin method, recovery was good at the intermediate and high concentrations, less so at low concentrations.
Recovery for the total-insulin method was better than for the free-insulin method but also was less so at lower concentrations.
The percent recovery we found for direct use of serum by the "Phadebas" method agrees well with other studies (5, 7) .
It Clinical Evaluation stored at -20 #{176}C until used. In addition, duplicate assays were performed on each pooled serum to establish a baseline value before freezing. The tests were performed on different days by thawing tubes of the three pooled sera and preparing free and total PEG extracts as described under Procedure. Table 2 shows our results for between-run precision. The insulin concentration of the three pooled sera, as established by the "Phadebas" method on the unfrozen sera were 20, 45, and 93 microunits/ml.
The mean values for the 15 different determinations by both methods for the three pooled sera agreed quite well with the average values determined by the "Phadebas" method ( Table 2 ). The coefficient of variation for both methods is slightly larger than the approximate 10% CV obtainable with the "Phadebas" comparison method.
Within-run reproducibility was studied by using selected patients' sera. The specimens were screened for insulin antibodies again by measuring free and total insulin, so that results by both methods could be better correlated ( Blood samples were drawn from a control group of 15 nonhospitalized and apparently normal people. These subjects were screened for diabetes, but no other disease was considered. All subjects had not eaten for at least 4 h and were considered to be in a fasting state.
Blood was sampled from another group of 17 nonfasting, nondiabetic subjects, all of whom were hospitalized for problems other than diabetes. All specimens were assayed for free and total insulin. In addition, since none of the subjects had received exogenous insulin and no insulin-binding antibodies could be present to invalidate the results, the "Phadebas" comparison method was also used. The results for the first group compares favorably with figures given by Velasco et al. (7) and others (5) . Table 4 also shows our results for the free and total insulin methods and the correlation with the comparison method.
The data from the second group are also summarized in Table 4 . It can be seen that the mean values for each of the three methods are greater than for the fasting group, as would be expected.
We Results for free-insulin ranged from 10 to 440 microunits/mi (mean, 47). The time at which blood specimens were collected varied from 0800 h to 1500 h, which would influence the results for free circulating insulin. In this group the insulin is almost all exogenous insulin, derived from the intramuscular injection given sometime during the day, usually early in the morning.
Its concentration at any given time depends on a number of factors, including the amount and solubility of the exogenous insulin injected and the rate at which it is released from the site of injection, the concentration of circulating insulin-binding antibody, the rate at which the free insulin is degraded in the liver, and bodily requirements for energy from carbohydrate and fat metabolism. Table 5 illustrates the lack of correlation between results of the free-insulin method and total insulin method in insulin-treated diabetic patients, in contrast to the correlation found if insulin antibodies are not present (Table 4 ). As indicated in Table 5 , insulin-binding was measurable in all of these 21 patients.
